U-Blot® Brodalumab Polyclonal AntibodyCat. No. WP26437Request quote
Size: 50μL/100μL
Polyclonal antibodies are produced from the serum of immunized animals and target multiple epitopes on antigens. They deliver robust binding signals, high experimental tolerance, short production cycles and excellent cost-effectiveness. They are ideal for preliminary target verification and short-term research applications.
U-Blot® Brodalumab Polyclonal AntibodyCat. No. WP26437
U-Blot® Inotuzumab Polyclonal AntibodyCat. No. WP26436
U-Blot® Benralizumab Polyclonal AntibodyCat. No. WP26435
U-Blot® Emicizumab Polyclonal AntibodyCat. No. WP26434
U-Blot® Burosumab Polyclonal AntibodyCat. No. WP26433
U-Blot® Ibalizumab Polyclonal AntibodyCat. No. WP26432
U-Blot® Tildrakizumab Polyclonal AntibodyCat. No. WP26431
U-Blot® Erenumab Polyclonal AntibodyCat. No. WP26430
U-Blot® Mogamulizumab Polyclonal AntibodyCat. No. WP26429
U-Blot® Lanadelumab Polyclonal AntibodyCat. No. WP26428
U-Blot® Galcanezumab Polyclonal AntibodyCat. No. WP26427
U-Blot® Moxetumomab Polyclonal AntibodyCat. No. WP26426